1. Evolutionary aspects of ABO blood group in humans
    Massimo Franchini et al, 2015, Clinica Chimica Acta CrossRef
  2. null
    Nilufer Rahmioglu et al, 2017 CrossRef
  3. Genetic predisposition to pancreatic cancer
    Paola Ghiorzo, 2014, WJG CrossRef
  4. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation
    Daniele Campa et al, 2018, Int. J. Cancer CrossRef
  5. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
    Paula Ghaneh et al, 2018, Health Technol Assess CrossRef
  6. ABO blood group is a predictor of survival in patients with laryngeal cancer
    Ting Jin et al, 2016, Chin J Cancer CrossRef
  7. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study.
    Renata Talar-wojnarowska, 0 CrossRef
  8. Epidemiology and burden of pancreatic cancer
    Patrick Maisonneuve, 2019, La Presse Médicale CrossRef
  9. Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese.
    Makoto Ueno et al, 0 CrossRef
  10. Pancreatic cancer.
    Jorg Kleeff et al, 2016, Nat Rev Dis Primers CrossRef
  11. null
    Paolo Boffetta et al, 2014 CrossRef
  12. Hemostasis, cancer, and ABO blood group: the most recent evidence of association
    Giancarlo Maria Liumbruno et al, 2014, J Thromb Thrombolysis CrossRef
  13. Incidence and Metastasis of Cutaneous Malignant Melanoma with Respect to ABO Blood Groups: A Case-Controlled Study in Northeast of China
    Liang Chang et al, 2014, PLoS ONE CrossRef
  14. ABO Blood Groups and Risk of Cancer: a Systematic Review and Meta-analysis
    Bai-Lin Zhang et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  15. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research
    Nilufer Rahmioglu et al, 2014, Fertility and Sterility CrossRef
  16. ABO blood types and cancer risk—A cohort study of 339,432 subjects in Taiwan
    Wenjie Sun et al, 2015, Cancer Epidemiology CrossRef
  17. Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis
    Yun-Fei Duan et al, 2015, Tumor Biol. CrossRef
  18. Pankreaskarzinom
    Florian Obermair et al, 2016, Wien klin Mag CrossRef
  19. Blood type, ABO genetic variants, and ovarian cancer survival
    Gabriella D. Cozzi et al, 2017, PLoS ONE CrossRef
  20. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival
    Khadija El Jellas et al, 2017, Cancer Med CrossRef
    Siladri Sengupta et al, 2017, jemds CrossRef
  22. null
    Himanshu Tillu et al, 2019 CrossRef
  23. Prognostic impact of Charlson’s Age‐Comorbidity Index and other risk factors in patients with pancreatic cancer
    Karin Bagni et al, 2020, Eur J Cancer Care CrossRef
  24. Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysis
    Yanxia Li et al, 2020, BMC Med Genet CrossRef
  25. Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?
    Dominique Lombardo et al, 2018, Oncotarget CrossRef
  26. Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma
    Miquel Porta et al, 2020, Environmental Research CrossRef
  27. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
    Renata Talar-wojnarowska, 0 CrossRef
  28. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1
    Sjoerd Nell et al, 2015 CrossRef
  29. Germline genetic variability in pancreatic cancer risk and prognosis
    Manuel Gentiluomo et al, 2020, Seminars in Cancer Biology CrossRef
  30. A phenome-wide association study of ABO blood groups
    Shun Li et al, 2020, BMC Med CrossRef
  31. Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms
    Gabriele Capurso et al, 2020, JAMA Netw Open CrossRef
  32. A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk
    Zhuo-Miao Ye et al, 2020, Aging CrossRef
  33. null
    Patrick Maisonneuve, 2021 CrossRef
  34. Identifying Clinical Detection in Disease Context by Computational Mining of PubMed
    Xiaoxue Fu et al, 2021, J. Phys.: Conf. Ser. CrossRef
  35. Molecular Processes Involved in Pancreatic Cancer and Therapeutics
    Subhajit Makar et al, 2021, CCB CrossRef
  36. null
    Ana Azanjac Arsic, 2021 CrossRef
  37. Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors
    Yakup Ergun et al, 2021, CBM CrossRef
  38. Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium
    Ludmila Vodickova et al, 2022 CrossRef
  39. The prognostic impact of ABO blood type in pancreatic cancer: Relevance to adjuvant chemotherapy.
    Koji Tezuka et al, 2022, J Hepatobiliary Pancreat Sci CrossRef
  40. Association of ABO Blood Group Antigen and Neurological Tumors
    Gopal K. Patidar et al, 2022, J Neuroanaesth Crit Care CrossRef
  41. A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs
    Matteo Giaccherini et al, 2022 CrossRef
  42. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women
    Giulia Peduzzi et al, 2022, Sci Rep CrossRef
  43. Prevalence of ABO Blood Grouping among Hemodialysis Patients in Dubai
    Fakhriya Alalawi et al, 2022, NEMJ CrossRef